期刊文献+

FISH技术在中国人膀胱尿路上皮癌诊断及复发监测中应用的研究 被引量:6

Diagnosis of Urothelial Carcinoma of Urinary Bladder Using Fluorescence in Situ Hybridization Technique
原文传递
导出
摘要 目的:应用荧光原位杂交(FISH)技术分析中国人膀胱尿路上皮癌中染色体拷贝数异常情况,评估FISH技术在中国人群中膀胱尿路上皮癌诊断及监测复发中的作用。方法:应用CSP3/CSP7、CSP17/GLP16两组混合探针,通过在膀胱癌病理石蜡切片标本上进行FISH反应,统计染色体拷贝异常情况,并分析其与肿瘤病理分期、分级,肿瘤大小、复发的关系以及染色体畸变率组合诊断膀胱尿路上皮癌的阳性率。结果:3、7、17号染色体及9p21区域的畸变率分别为53.2%、59.7%、61%和57.1%,染色体拷贝数异常与肿瘤分期无相关性(P>0.05),3、7、17号染色体畸变与病理分级有显著相关性(P<0.01),3、7、17号染色体及9p21区域畸变与复发显著相关(P<0.01)9p21区域畸变情况与肿瘤大小具有相关性(P<0.05),FISH探针组合诊断膀胱尿路上皮癌的总阳性率为72.7%。结论:FISH技术有助于探索3号、7号、17号及9p21区域畸变与膀胱尿路上皮癌的病理分期、分级、肿瘤大小及复发之间的关系,并可以作为预测膀胱尿路上皮癌术后复发的有用的指标。 Objective:To analyze the usefulness of FISH (fluorescence in situ hybridization) in the diagnosis of urothelial carcinoma of urinary bladder in Chinese. Methods:The FISH probes, directqabeled to the peri-centromeric regions of chromosomes 3,7 and 17 as well as the 9p21 locus, were performed on paraffin sections of 77 urinary bladder cancer cases which were selected at random from 2007 to 2010. Results:The rates of aneuploidy of chromosomes 3.7 and 17 were 53.2%.59.7%.61% and 57.1% for aberration of 9p21 locus in urothelial carcinoma. The aberrations of chromosomes 3,7, and 17 were significantly associated with grade and recurrences(P〈0. 01), hut not with stage(P〉0.05). The aberrations of 9p21 locus had significantly correlation with recurrences(P〈0.01), but not with the stage and grade of the tumor(P〉0.05). Conclusions: FISH technique may be a valuable method for the diagnosis of the patients with urothelial carcinoma.
出处 《临床泌尿外科杂志》 北大核心 2011年第11期823-826,共4页 Journal of Clinical Urology
基金 安徽省科技厅科研基金项目(编号08020303084)
关键词 膀胱肿瘤 荧光原位杂交技术 bladder cancer fluorescence in situ hybridization
  • 相关文献

参考文献16

  • 1全国肿瘤防治研究办公室卫生部统计信息中心.中国卫生统计提要前十位恶性肿瘤死亡率[R].2008C,2004-2005,52-53.
  • 2Tolley D A,Parmar M K,Grigor K M,et al. The effect of intravesical mitomycin C on recurrence of newly diag- nosed superficial bladder cancer; a further report with years of follow up[J]. J Urol, 1996,155 : 1233-1238.
  • 3Sarosdy M F,Schellhammer P,Bokinsky G,etal. Clinical evaluation of a multi-target fluorescence in situ hybridiza- tion assay for detection of bladder cancer[J]. J Urol, 2002,168 : 1950-1954.
  • 4张业贵,毕新刚,韩亚玲,蔡岩,徐昕,吴玉鹏,杨壹羚,马建辉,赵平,贾雪梅,王明荣.多色荧光原位杂交在膀胱尿路上皮癌诊断中的应用[J].癌症,2007,26(2):189-193. 被引量:27
  • 5Mhawech-Fauceglia P,Fischer G,Beck A,et al. Rafl,Au- rora-A/STK15 and E-cadherin biomarkers expression in patients with pTa /pT1 urot~elial bladder eareinoma;a ret- rospective TMA study of 246 patients with long-term fol- low-up [J]. Eur J Surg 0ncol,2006,32:439-444.
  • 6Simon R, Btirger H, Brinkschmidt C, et al. Chromo- somal aberrations associated with invasion in papillary superficial bladder caneer[J]. J Pathol, 1998,185 : 345 -351.
  • 7Qureshi K N,Lunec J,Neal D E. Molecular biological changes in bladder cancer[J]. Cancer Surv, 1998,31 : 77-97.
  • 8Sauter G, Moch H, Carroll P, et al. Chromosome- 9 loss detected by fluorescence in situ hybridization in bladder caneer[J]. Int J Cancer, 1995,64 : 99- 103.
  • 9Watters A D,Ballantyne S A,Going J J,et al. Aneu- somy of chromosome 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder [J]. BJU Int,2000,85:42-47.
  • 10Krtiger S,Mess F,B~hle A,et al. Numerical aberra tions of chromosome 17 and the 9p21 locus are inde pendent predictors of number recurrence in non-inva sive transitional cell carcinoma of urinary hladder[J]. Int J Oncol,2003,23:41-48.

二级参考文献34

  • 1乔忠杰,王国民.膀胱癌复发与染色体畸变关系的研究进展[J].国外医学(泌尿系统分册),2005,25(2):167-170. 被引量:5
  • 2张业贵,毕新刚,韩亚玲,蔡岩,徐昕,吴玉鹏,杨壹羚,马建辉,赵平,贾雪梅,王明荣.多色荧光原位杂交在膀胱尿路上皮癌诊断中的应用[J].癌症,2007,26(2):189-193. 被引量:27
  • 3Sokolova I A,Halling K C,Jenkins R B, et al. The development of a multitarget multicolor fluotescence in situ hybridization assay for the dectection of urothelial carcinoma in urine[J].J Mol Diagn, 2000, 2 (3) : 116-123.
  • 4Maria C, Aleksandra B K, Edyta B, et al. Application of multiplex FISH, CGH and MSSCP techniques for cytogenetic and molecular analysis of transitional cell carcinoma (TCC) cells in voided urine specimens[J]. J Appl Genet, 2006, 47(3):73-275.
  • 5Brian J Y, Marek S, Ryan H, et al. Reflex urovysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology. A prospective study with focus on the natural history of anticipatory positive findings [J]. Am J Clin Pathol, 2007, 127:295-301.
  • 6Sarosdy M F, Kahn P R, Ziffer M D, et al. Evaluation of a multitarget fluorescent in-situ hybridization (FISH) assay in the initial diagnosis of bladder cancer in patients with hematuria[J]. J Urol, 2004, 171(Suppl) : 66.
  • 7Peter RIESZ, Gabor LOTZ, Csilla PASKA, et al. Detection of bladder cancer from the urine using fluorescence in situ hybridization technique[J].Pathology Ontology Resareh, 2007, 13(3) :187-194.
  • 8Skacel M, Fahmy, Brainard J, et al. Multitarget fluorescence in situ hybridization assay dectects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology [J]. J Urol, 2003, 169:2101-2105.
  • 9Raitanen M P, Kaasinen E, Lukkarinen O, et al. Analysis of false-positive BAT Stat test results in patients followed up for bladder cancer [J]. Urology, 2001, 57:680-684.
  • 10Mian C, Lodde M, Comploj E, et al. Multiprobe fluorescence in situ hybridization:prognostic perspectives in superficial bladder cancer[J]. Journal of Clinical Pathology, 2006, 59:984-987.

共引文献45

同被引文献39

  • 1Halling KC, Kipp BR. Bladder cancer detection using FISH (UroVysion Assay) [J]. Adv Anat Pathol, 2008,15 (5) :279- 286.
  • 2Xu CL, Zeng QS, Hou JG, et al. Utility of a modality combining fish and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients [ J ]. Urology, 2011,77 (3) : 636-641.
  • 3Petrov SV, Malkhasyan KA, Ulyanin MY, et al. The value of the preopera tive FISH test in unscreened bladder cancer patients with TUR indications [J]. Pathol Oncol Res, 2012,18 (4) : 1059-1066.
  • 4Sevankaev A, Lushnikov E, Karyakin O, et al. Clinical use of the FISH method in early detection of superficial bladder cancer [J]. Oneourology, 2008, 4 : 61-65.
  • 5Riesz P, Lotz G, Paska C, et al. Detection of bladder cancer from the urine using fluorescence in situ hybridization technique [J]. Pathol Oncol Res, 2007,13(3) : 187-194.
  • 6Jones JS. DNA-based molecular cytology for bladder cancer surveillance [ J ]. Urology, 2006,67 ( 3 ) : 35.
  • 7Goebell PJ, Knowles MA. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium [J]. Urol Oncol, 2010,28 (4) : 409 -428.
  • 8SEIDEMAN C, CANTER D, KIM P, et al. Mnlticenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence? [J]. World J Urol, 2015, 33(9) : 1309-1313.
  • 9MATSUYAMA H, IKEMOTO K, EGUCHI S, et al. Copy number aberrations using muhicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscle- invasive bladder cancer (NIMBC) [Jl. BJU Int, 2014, 113 (4) :662-667.
  • 10KAWAUCHI S, SAKAI H,IKEMOTO K, et al. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology [J]. Hum Pathol, 2009, 40(12) : 1783-1789.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部